Department of Cardiology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Institute of Cardiovascular Disease, Peking University First hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Lipids Health Dis. 2021 Jun 26;20(1):60. doi: 10.1186/s12944-021-01490-0.
The lipid profile is reportedly related to peripheral blood pressure or pulse wave velocity. However, no studies have investigated the associations between lipid parameters, especially remnant lipoprotein cholesterol (RLP-C), and central systolic blood pressure (cSBP).
This study used baseline data of a community-based cohort in Beijing, China. Participants who had been treated with anti-hypertensive or lipid-lowering agents were excluded. RLP-C is equal to total cholesterol (TC) minus the sum of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). An Omron HEM-9000AI device was used to measure non-invasive cSBP. The associations between blood lipid profile and non-invasive cSBP were evaluated using multivariable regression models.
The 5173 included participants were 55.0 ± 8.5 years old; 35.7% (1845) of participants were men. Increased cSBP was significantly associated with increased TC, LDL-C, non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride (TG), and RLP-C but with decreased HDL-C, even after adjusting for possible covariates. When simultaneously entering individual pairs of RLP-C and other blood lipid parameters into the multivariable regression model, RLP-C remained significantly associated with cSBP, even after adjusting for other lipids. Compared with participants who had RLP-C levels in the first quartile (Q1), cSBP for those with RLP-C in Q4 was increased to 4.57 (95% confidence interval [CI]: 3.08-6.06) mmHg after adjusting for LDL-C, 4.50 (95%CI: 2.98-6.02) mmHg after adjusting for TC, 3.91 (95%CI: 1.92-5.89) mmHg after adjusting for TG, 5.15 (95%CI: 3.67-6.63) mmHg after adjusting for HDL-C, and 4.10 (95%CI: 2.36-5.84) mmHg after adjusting for non-HDL-C.
Increased blood RLP-C level was significantly associated with higher cSBP in a Chinese population, independently of other lipids, which indicates its importance in individual cardiovascular risk assessment.
据报道,血脂谱与外周血压或脉搏波速度有关。然而,尚无研究调查脂质参数(尤其是残粒脂蛋白胆固醇[RLP-C])与中心收缩压(cSBP)之间的关系。
本研究使用了中国北京一个基于社区的队列的基线数据。排除了已接受抗高血压或降脂药物治疗的参与者。RLP-C 等于总胆固醇(TC)减去低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)的总和。使用欧姆龙 HEM-9000AI 设备测量非侵入性 cSBP。使用多变量回归模型评估血脂谱与非侵入性 cSBP 之间的关系。
纳入的 5173 名参与者年龄为 55.0±8.5 岁;35.7%(1845 名)为男性。cSBP 升高与 TC、LDL-C、非高密度脂蛋白胆固醇(non-HDL-C)、甘油三酯(TG)和 RLP-C 升高显著相关,但与 HDL-C 降低相关,即使在调整了可能的混杂因素后也是如此。当将 RLP-C 与其他单个血脂参数同时输入多变量回归模型时,即使在调整了其他脂质后,RLP-C 仍与 cSBP 显著相关。与 RLP-C 水平处于第一四分位数(Q1)的参与者相比,调整 LDL-C 后,RLP-C 处于第四四分位数(Q4)的参与者的 cSBP 升高至 4.57(95%置信区间[CI]:3.08-6.06)mmHg,调整 TC 后为 4.50(95%CI:2.98-6.02)mmHg,调整 TG 后为 3.91(95%CI:1.92-5.89)mmHg,调整 HDL-C 后为 5.15(95%CI:3.67-6.63)mmHg,调整 non-HDL-C 后为 4.10(95%CI:2.36-5.84)mmHg。
在中国人群中,血液 RLP-C 水平升高与 cSBP 升高显著相关,与其他脂质无关,这表明其在个体心血管风险评估中的重要性。